‘At the point at which you can do something about it, then it becomes more relevant’: Informed consent in the pharmacogenetic clinic-Reference-Cited by-同舟云学术

‘At the point at which you can do something about it, then it becomes more relevant’: Informed consent in the pharmacogenetic clinic

Published:2005-09 Issue:6 Volume:61 Page:1201-1210
ISSN:0277-9536
Container-title:Social Science & Medicine
language:en
Short-container-title:Social Science & Medicine

Author:

Hedgecoe Adam

Publisher

Elsevier BV

Subject

History and Philosophy of Science,Health (social science)

Reference70 articles.

1. Altman, L. K. (2000). Reading the book of life: the doctor's world; genomic chief has high hopes, and great fears, for genetic testing. The New York Times, 27 June, Section F, p. 6.

2. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group;Anderson;The Pharmacogenomics Journal,2002

3. Current and future applications of pharmacogenomics;Anderson;New Horizons: Science and Practice of Acute Medicine,1999

4. Deciding who Lives: Fateful choices in the intensive-care nursery;Anspach,1993

5. Do we need a strong programme in medical sociology?;Bartley;Sociology of Health & Illness,1990

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A SHORT REVIEW OF THE PROFESSIONALS AND GENERAL PUBLIC ATTITUDES AND CONCERNS ABOUT PHARMACOGENETIC TESTING WITH THE RECOGNITION OF THE PHARMACISTS ROLE;FARMACIA;2018-10-13

2. Collaborative Counseling Considerations for Pharmacogenomic Tests;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2017-08-07

3. A review of consent practices and perspectives for pharmacogenetic testing;Pharmacogenomics;2016-09

4. Stratified, precision or personalised medicine? Cancer services in the ‘real world’ of a London hospital;Sociology of Health & Illness;2016-07-27

5. Personalized medicine and genome-based treatments: Why personalized medicine ≠ individualized treatments;Clinical Ethics;2014-11-12